Searched for
RHEUMATOID ARTHRITIS TREATMENT
Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- 5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Time to take the first step to become a contrarian? 4 mid-cap stocks from different sectors with upside potential up to 21%As the risk created by the US-Iran war keeps crude oil prices elevated, the list of stocks where investors can deploy fresh money with comf...
- A massive DNA discovery just rewrote everything we thought we knew about the Japanese peopleA groundbreaking DNA study has uncovered evidence of a third ancestral group contributing to Japan's population, originating from northeast...
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...
- Diabetes, rheumatoid arthritis, sclerosis, lupus be cured? Scientists are trying revolutionary approach to treat autoimmune diseasesWhen your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they don’t fix what’...
- What causes rheumatoid arthritis? Breakthrough research trace condition to gut microbiomeThe origins of antibodies that cause rheumatoid arthritis have been an area of study for years.
- World Autoimmune Arthritis Day: Don't let pain dominate your life. Early treatment, lifestyle changes are keyRheumatoid arthritis affects about 1 in 100 Indians.
- Don't ignore joint pain with fever, fatigue: It can mean rheumatoid arthritisRheumatoid arthritis, an autoimmune disease, tends to affect women more than men.
- Drink green tea to combat rheumatoid arthritisExisting drugs for rheumatoid arthritis are expensive and sometimes unsuitable for long-term use.
- Roche gets nod for Mabthera for arthritisRoche has received approval for its drug Mabthera (rituximab) in India for the treatment of rheumatoid arthritis.
- Now, a golden cure for arthritisInjecting gold into knees affected by osteoarthritis may ease pain and slow down the progress of the disease, but scientists say it does no...
Load More
